Clinical efficacy of erythropheresis in high altitude polycythemia among permanent soldiers in highland: a randomized controlled trial.

Clinical efficacy of erythropheresis in high altitude polycythemia among permanent soldiers in highland

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000034553

Enrollment

Unknown

Registered

2020-07-09

Start date

2020-07-13

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

high altitude polycythemia

Interventions

experimental group:erythropheresis theropy

control group:conventional therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. adult soldiers who have been in highland for over 12 months and diagnosed as high altitude polycythemia; 2. patients admitted in branch No.953 Hospital of Xinqiao Hospital ; 3. general examinations such as chest X-ray, electrocardiogram indicate no other complications; 4. without acute or chronic infections and medication history ; 5. patients who are informed and informed consent form are acquired.

Exclusion criteria

Exclusion criteria: 1. not the Han nationality; 2. patients may have others respiratory or cardiac diseases to cause hypoxemia or polycythemia vera; 3. patients who are acute or subacute mountain sickness ; 4. patients with psychiatric disorders or severe neurosis; 5. patients with malignant myeloproliferative disease; 6. patients who are informed and informed consent form are acquired.

Design outcomes

Primary

Measure	Time frame
6-Minute Walk Test;oxygen saturation of blood;arterial partial pressure of oxygen;	—

Countries

China

Contacts

Public ContactYe Fan

Xinqiao Hospital

83728087@qq.com+86 13983815728

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026